Preprint / Version 1

Lipidomics Analysis Indicates Disturbed Hepatocellular Lipid Metabolism in Reynoutria multiflora-Induced Idiosyncratic Liver Injury

Authors

  • Xiaofang Wu The Second Clinical College, Guangzhou University of Chinese Medicine, Guangzhou, China
  • Xiaohui Qiu The Second Clinical College, Guangzhou University of Chinese Medicine, Guangzhou, China
  • Zhihai Huang Key Laboratory of Quality Evaluation of Chinese Medicine of the Guangdong Provincial Medical Products Administration, Guangzhou, China
  • Junqi Bai The Second Clinical College, Guangzhou University of Chinese Medicine, Guangzhou, China
  • Juan Huang The Second Clinical College, Guangzhou University of Chinese Medicine, Guangzhou, China
  • Jing Zhang The Second Clinical College, Guangzhou University of Chinese Medicine, Guangzhou, China
  • Ya Xu The Second Clinical College, Guangzhou University of Chinese Medicine, Guangzhou, China
  • Jiaqi Qiu The Second Clinical College, Guangzhou University of Chinese Medicine, Guangzhou, China
  • Yating Zhang The Second Clinical College, Guangzhou University of Chinese Medicine, Guangzhou, China
  • Wen Xu The Second Clinical College, Guangzhou University of Chinese Medicine, Guangzhou, China

Keywords:

Polygonum multiflorum, phospholipid metabolism, hepatotoxicity, phosphatidylcholine, phosphatidylethanolamine, Reynoutria multiflora

Abstract

The root of Reynoutria multiflora (Thunb.) Moldenke (syn.: Polygonum multiflorum Thunb., HSW) is a distinguished herb that has been popularly used in traditional Chinese medicine (TCM). Evidence of its potential side effect on liver injury has accumulated and received much attention. The objective of this study was to profile the metabolic characteristics of lipids in injured liver of rats induced by HSW and to find out potential lipid biomarkers of toxic consequence. A lipopolysaccharide (LPS)-induced rat model of idiosyncratic drug-induced liver injury (IDILI) was constructed and evident liver injury caused by HSW was confirmed based on the combination of biochemical, morphological, and functional tests. A lipidomics method was developed for the first time to investigate the alteration of lipid metabolism in HSW-induced IDILI rat liver by using ultra-high-performance liquid chromatography/Q-exactive Orbitrap mass spectrometry coupled with multivariate analysis. A total of 202 characterized lipids, including phosphatidylcholine (PC), lysophosphatidylcholine (LPC), phosphatidylethanolamine (PE), lysophosphatidylethanolamine (LPE), sphingomyelin (SM), phosphatidylinositol (PI), lysophosphatidylinositol (LPI), phosphatidylserine (PS), phosphoglycerols (PG), and ceramide (Cer), were compared among groups of LPS and LPS + HSW. A total of 14 out 26 LPC, 22 out of 47 PC, 19 out of 29 LPE, 16 out of 36 PE, and 10 out of 15 PI species were increased in HSW-treated rat liver, which indicated that HSW may cause liver damage via interfering the phospholipid metabolism. The present work may assist lipid biomarker development of HSW-induced DILI and it also provide new insights into the relationships between phospholipid perturbation and herbal-induced idiosyncratic DILI. Keywords: Polygonum multiflorum, phospholipid metabolism, hepatotoxicity, phosphatidylcholine, phosphatidylethanolamine, Reynoutria multiflora

Author Biographies

Xiaohui Qiu, The Second Clinical College, Guangzhou University of Chinese Medicine, Guangzhou, China

Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome, Guangzhou, China

Zhihai Huang, Key Laboratory of Quality Evaluation of Chinese Medicine of the Guangdong Provincial Medical Products Administration, Guangzhou, China

Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China

Jing Zhang, The Second Clinical College, Guangzhou University of Chinese Medicine, Guangzhou, China

Key Laboratory of Quality Evaluation of Chinese Medicine of the Guangdong Provincial Medical Products Administration, Guangzhou, China

Wen Xu, The Second Clinical College, Guangzhou University of Chinese Medicine, Guangzhou, China

Key Laboratory of Quality Evaluation of Chinese Medicine of the Guangdong Provincial Medical Products Administration, Guangzhou, China

Downloads